Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

CATL (3750HK / 3000750 CH): Market Leader at a Discount - 2Q26 Review

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Event-Driven

Contemporary Amperex Technology / Event-Driven

Contemporary Amperex Technology (3750 HK)

<ul>
<li>We update the A+H cornerstone lock-up expiry study with 18 deals and a longer post-expiry observation window.</li>
<li>The revised pattern is timing-driven. Early post-expiry trading was resilient, while weakness appeared later than the February note captured.</li>
<li>A-H premium is a clear cross-sectional screen in this sample.</li>
</ul>


We update the A+H cornerstone lock-up expiry study with 18 deals and a longer post-expiry observation window.
The revised pattern is timing-driven. Early post-expiry trading was resilient, while weakness appeared later than the February note captured.
A-H premium is a clear cross-sectional screen in this sample.


China VAST Industrial Urban Development (CVI HK)

Suzhou Novosense Microelectronics (2676 HK)

Shenzhen Woer Heat-Shrinkable Material (9981 HK)

HK A+H IPO Cornerstone Lock-Up Expiry: Price and Liquidity Evidence (Updates)